Abstract
During a 3-year period (June 1981-July 1984), 70 patients who presented with an endoscopically proven variceal bleed were randomized to receive either fiberoptic injection sclerotherapy (FIS, 36 patients) or a rigid scope technique (RIS, 34 patients), using ethanolamine oleate as the sclerosing agent. After discharge, patients entered into a chronic injection sclerotherapy program. Control of the acute bleeding episode (FIS, 91%, RIS, 95%) and the first hospital admission mortality (FIS, 34%, RIS, 44%) were similar. Eradication of varices was achieved in 16/19 and 13/16 cases in the two respective groups of patients who survived longer than 3 months, and only 2 of these patients (both of whom were in the RIS group) had a further major variceal bleed. The overall complication rate per injection was significantly lower in the FIS group (p less than 0.005). Twenty-six patients (14 FIS, 12 RIS) were alive at the end of the 4-year trial period. Of the total of 44 deaths, only 3 were not associated with a bleeding episode. Only five of the 29 patients who had their varices eradicated died during the trial period (median follow-up of 16 months). FIS has become the preferred method of treatment at the Groote Shuur Hospital, particularly in the long-term management of these patients. The procedure is safe, does not require a general anesthetic, and in long-term management, most patients can be treated on an outpatient basis. RIS should be reserved for the difficult recurrent acute bleeder, where the more controlled situation with a rigid scope under general anesthesia may provide safer and more effective sclerotherapy. The study stresses the importance of achieving eradication of all varices to prevent rebleeding and its attendant high mortality.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bornman P. C., Terblanche J., Kahn D., Jonker M. A., Kirsch R. E. Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J. 1986 Jul 5;70(1):34–36. [PubMed] [Google Scholar]
- Cello J. P., Grendell J. H., Crass R. A., Trunkey D. D., Cobb E. E., Heilbron D. C. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984 Dec 20;311(25):1589–1594. doi: 10.1056/NEJM198412203112501. [DOI] [PubMed] [Google Scholar]
- Hunt P. S., Korman M. G., Hansky J. Management of bleeding oesophageal varices: an eight-year prospective study. Med J Aust. 1982 Feb 6;1(3):121–124. doi: 10.5694/j.1326-5377.1982.tb132199.x. [DOI] [PubMed] [Google Scholar]
- Johnston G. W., Rodgers H. W. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973 Oct;60(10):797–800. doi: 10.1002/bjs.1800601011. [DOI] [PubMed] [Google Scholar]
- Lewis J. W., Chung R. S., Allison J. G. Injection sclerotherapy for control of acute variceal hemorrhage. Am J Surg. 1981 Nov;142(5):592–595. doi: 10.1016/0002-9610(81)90433-5. [DOI] [PubMed] [Google Scholar]
- MACBETH R. Treatment of oesophageal varices in portal hypertension by means of sclerosing injections. Br Med J. 1955 Oct 8;2(4944):877–880. doi: 10.1136/bmj.2.4944.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacDougall B. R., Westaby D., Theodossi A., Dawson J. L., Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982 Jan 16;1(8264):124–127. doi: 10.1016/s0140-6736(82)90378-6. [DOI] [PubMed] [Google Scholar]
- Paquet K. J., Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology. 1985 Jul-Aug;5(4):580–583. doi: 10.1002/hep.1840050409. [DOI] [PubMed] [Google Scholar]
- Paquet K. J., Oberhammer E. Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy. 1978 Feb;10(1):7–12. doi: 10.1055/s-0028-1098252. [DOI] [PubMed] [Google Scholar]
- Sivak M. V., Jr, Stout D. J., Skipper G. Endoscopic injection sclerosis (EIS) of esophageal varices. Gastrointest Endosc. 1981 May;27(2):52–57. doi: 10.1016/s0016-5107(81)73148-1. [DOI] [PubMed] [Google Scholar]
- Terblanche J., Bornman P. C., Kahn D., Jonker M. A., Campbell J. A., Wright J., Kirsch R. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet. 1983 Dec 10;2(8363):1328–1332. doi: 10.1016/s0140-6736(83)91090-5. [DOI] [PubMed] [Google Scholar]
- Terblanche J., Northover J. M., Bornman P., Kahn D., Barbezat G. O., Sellars S. L., Saunders S. J. A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery. 1979 Mar;85(3):239–245. [PubMed] [Google Scholar]
- Terblanche J., Northover J. M., Bornman P., Kahn D., Silber W., Barbezat G. O., Sellars S., Campbell J. A., Saunders S. J. A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet. 1979 Mar;148(3):323–333. [PubMed] [Google Scholar]
- Terblanche J. The long-term management of patients after an oesophageal variceal bleed: the role of sclerotherapy. Br J Surg. 1985 Feb;72(2):88–90. doi: 10.1002/bjs.1800720204. [DOI] [PubMed] [Google Scholar]
- Terblanche J., Yakoob H. I., Bornman P. C., Stiegmann G. V., Bane R., Jonker M., Wright J., Kirsch R. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg. 1981 Oct;194(4):521–530. doi: 10.1097/00000658-198110000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]